Skip to navigation bar Skip to breadcrumbs Skip to page content
Envelope icon E-mail Updates Teal square Text size:  a A A
You are here: HomeAnnouncementsAnnouncement Detail

Public Comment on Draft Recommendation Statement: Low-dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia

The U.S. Preventive Services Task Force posted today its draft Recommendation Statement on low-dose aspirin for the prevention of morbidity and mortality from preeclampsia for public comment. The draft Recommendation Statement is available for review and public comment from April 8 through May 5, 2014. To review the draft Recommendation Statement and submit comments, go to http://www.uspreventiveservicestaskforce.org/tfcomment.htm.

Return to Announcements

Current as of: December 2018

Internet Citation: Public Comment on Draft Recommendation Statement: Low-dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia. U.S. Preventive Services Task Force. April 2014.
https://www.uspreventiveservicestaskforce.org/Announcements/News/Item/public-comment-on-draft-recommendation-statement-low-dose-aspirin-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia

USPSTF Program Office •  5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857